Organization

Clinical Vaccine

Kohtaro Fujihashi

To explore new avenues for mucosal vaccine development, investigators have begun to employ novel adjuvants and targeting mucosal tissues and immune cells for vaccine delivery. Despite recent advanced sciences, it still remains to develop effective mucosal vaccines for human use. To this end, our main task is to define the effectiveness and safety of novel mucosal vaccines including adjuvant- and delivery system-development, and bring them from bench-top to practical applications.

• 
• 
• 
• 
• 
• 
• 
•